Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 13, 2022

Total Value ($000): $478,655 (100.0% shares, 0.0% debt)

Holdings (18)

PATH UIPATH INC 17.2%

Value ($000) $82,296 Shares 3,811,779 Est. Cost $60.53 Unrealized -44.3%

NU NU HOLDINGS LTD. 14.7%

Value ($000) $70,536 Shares 9,136,835 Est. Cost $9.82 Unrealized -18.3%

DASH DOORDASH INC 14.7%

Value ($000) $70,484 Shares 601,454 Est. Cost $191.28 Unrealized -43.5%

— DICE THERAPEUTICS, INC. 12.6%

Value ($000) $60,240 Shares 3,148,970 Est. Cost $32.75 Unrealized —

SNOW SNOWFLAKE INC 10.3%

Value ($000) $49,176 Shares 214,621 Est. Cost $284.41 Unrealized -9.1%

— SAMSARA, INC. 9.1%

Value ($000) $43,450 Shares 2,712,256 Est. Cost $28.11 Unrealized —

— KARUNA THERAPEUTICS, INC. 7.1%

Value ($000) $33,966 Shares 267,895 Est. Cost $122.33 Unrealized —

— CINCOR PHARMA, INC. 3.5%

Value ($000) $16,663 Shares 950,000 Est. Cost $17.54 Unrealized —

ABOS ACUMEN PHARMACEUTICALS, INC 2.8%

Value ($000) $13,361 Shares 3,417,075 Est. Cost $16.64 Unrealized -67.3%

— OLINK HOLDING AB 1.6%

Value ($000) $7,515 Shares 425,514 Est. Cost $17.66 Unrealized —

MASS 908 DEVICES INC 1.3%

Value ($000) $6,205 Shares 326,427 Est. Cost $33.97 Unrealized -49.4%

IOT SAMSARA, INC. 1.1%

Value ($000) $5,223 Shares 326,000 Est. Cost $26.05 Unrealized -26.8%

TSHA TAYSHA GENE THERAPIES INC 1.0%

Value ($000) $4,726 Shares 724,873 Est. Cost $19.01 Unrealized -60.7%

TARS TARSUS PHARMACEUTICALS INC 0.9%

Value ($000) $4,373 Shares 260,000 Est. Cost $24.75 Unrealized -25.0%

RGEN REPLIGEN CORP. 0.9%

Value ($000) $4,240 Shares 22,544 Est. Cost $256.54 Unrealized -26.0%

CADL CANDEL THERAPEUTICS, INC 0.9%

Value ($000) $4,132 Shares 811,737 Est. Cost $8.29 Unrealized -40.1%

— SPRUCE BIOSCIENCES INC 0.3%

Value ($000) $1,582 Shares 787,007 Est. Cost $6.01 Unrealized —

ABSI ABSCI CORP. 0.1%

Value ($000) $487 Shares 57,804 Est. Cost $19.41 Unrealized -59.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PATH	UIPATH INC	3,811,779	$82,296	17.2%	$60.53	-44.3%	COM CL A	90364P105
NU	NU HOLDINGS LTD.	9,136,835	$70,536	14.7%	$9.82	-18.3%	COM CL A	G6683N103
DASH	DOORDASH INC	601,454	$70,484	14.7%	$191.28	-43.5%	COM CL A	25809K105
—	DICE THERAPEUTICS, INC.	3,148,970	$60,240	12.6%	$32.75	—	COM	23345J104
SNOW	SNOWFLAKE INC	214,621	$49,176	10.3%	$284.41	-9.1%	COM CL A	833445109
—	SAMSARA, INC.	2,712,256	$43,450	9.1%	$28.11	—	COM CL B	FDS1Q2O30
—	KARUNA THERAPEUTICS, INC.	267,895	$33,966	7.1%	$122.33	—	COM	48576A100
—	CINCOR PHARMA, INC.	950,000	$16,663	3.5%	$17.54	—	COM	17240Y109
ABOS	ACUMEN PHARMACEUTICALS, INC	3,417,075	$13,361	2.8%	$16.64	-67.3%	COM	00509G209
—	OLINK HOLDING AB	425,514	$7,515	1.6%	$17.66	—	COM	680710100
MASS	908 DEVICES INC	326,427	$6,205	1.3%	$33.97	-49.4%	COM	65443P102
IOT	SAMSARA, INC.	326,000	$5,223	1.1%	$26.05	-26.8%	COM CL A	79589L106
TSHA	TAYSHA GENE THERAPIES INC	724,873	$4,726	1.0%	$19.01	-60.7%	COM	877619106
TARS	TARSUS PHARMACEUTICALS INC	260,000	$4,373	0.9%	$24.75	-25.0%	COM	87650L103
RGEN	REPLIGEN CORP.	22,544	$4,240	0.9%	$256.54	-26.0%	COM	759916109
CADL	CANDEL THERAPEUTICS, INC	811,737	$4,132	0.9%	$8.29	-40.1%	COM	137404109
—	SPRUCE BIOSCIENCES INC	787,007	$1,582	0.3%	$6.01	—	COM	85209E109
ABSI	ABSCI CORP.	57,804	$487	0.1%	$19.41	-59.5%	COM	00091E109